Cargando…
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
Neutralizing antibodies represent a valuable therapeutic approach to countermeasure the current COVID-19 pandemic. Emergence of SARS-CoV-2 variants emphasizes the notion that antibody treatments need to rely on highly neutralizing monoclonal antibodies (mAbs), targeting several distinct epitopes for...
Autores principales: | Noy-Porat, Tal, Mechaly, Adva, Levy, Yinon, Makdasi, Efi, Alcalay, Ron, Gur, David, Aftalion, Moshe, Falach, Reut, Leviatan Ben-Arye, Shani, Lazar, Shirley, Zauberman, Ayelet, Epstein, Eyal, Chitlaru, Theodor, Weiss, Shay, Achdout, Hagit, Edgeworth, Jonathan D., Kikkeri, Raghavendra, Yu, Hai, Chen, Xi, Yitzhaki, Shmuel, Shapira, Shmuel C., Padler-Karavani, Vered, Mazor, Ohad, Rosenfeld, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074524/ https://www.ncbi.nlm.nih.gov/pubmed/33937725 http://dx.doi.org/10.1016/j.isci.2021.102479 |
Ejemplares similares
-
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021) -
Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
por: Bar-On, Liat, et al.
Publicado: (2022) -
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
por: Noy-Porat, Tal, et al.
Publicado: (2020) -
Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
por: Makdasi, Efi, et al.
Publicado: (2021) -
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
por: Levy, Yinon, et al.
Publicado: (2022)